Trial Profile
Efficacy of the Subcutaneous Formulation of Abatacept/Orencia in Rheumatoid Arthritis, a Single-Center Italian Experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2015
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Abatacept
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 26 Aug 2015 New trial record